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Unsaturated aldehydeodiﬁcations induced by reactive carbonyl species (RCS) generated by peroxidation
of membrane phospholipids acyl chains play a causal role in the aging process. Most of the biological effects
of RCS, mainly α,β-unsaturated aldehydes, di-aldehydes, and keto-aldehydes, are due to their capacity to
react with cellular constituents, forming advanced lipoxidation end-products (ALEs). Compared to reactive
oxygen and nitrogen species, lipid-derived RCS are stable and can diffuse within or even escape from the cell
and attack targets far from the site of formation. Therefore, these soluble reactive intermediates, precursors
of ALEs, are not only cytotoxic per se, but they also behave as mediators and propagators of oxidative stress
and cellular and tissue damage. The consequent loss-of-function and structural integrity of modiﬁed
biomolecules can have a wide range of downstream functional consequences and may be the cause of
subsequent cellular dysfunctions and tissue damage. The causal role of ALEs in aging and longevity is inferred
from the ﬁndings that follow: a) its accumulation with aging in several tissues and species; b) physiological
interventions (dietary restriction) that increase longevity, decrease ALEs content; c) the longer the longevity
of a species, the lower is the lipoxidation-derived molecular damage; and ﬁnally d) exacerbated levels of
ALEs are associated with pathological states.
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Aging causes a multitude of detrimental changes in all animal
species at all levels of biological organization, decreases maximum
functional capacities and homeostasis, and increases the probability of
suffering degenerative processes and ﬁnally death. All these changes
probably originate from a small number of basic causes that
continuously operate throughout the lifespan. The basic chemical
and biological processes underlying aging and longevity can be
explained and predicted by the mitochondrial oxidative stress theory
of aging [1–3]: the reaction of reactive oxygen species (ROS),
physiologically generated by mitochondrial electron transport chain,
with cellular constituents' initiates the changes associated with aging
and determines the maximum longevity.
The involvement of oxidative stress in aging is intrinsically related
to their key role in the origin and evolution of life. Oxidative stress is
not only a natural consequence of aerobic life, but it has also been a
determinant factor which demanded structural and functional
adaptations to the cells and organisms that, in turn, determined
their longevities [4]. Available evidences suggest that aerobic life, and
long-lived species, evolved by reducing the relative abundance of
those structural components that are highly susceptible to oxidative
damage, but without renouncing them, thus conferring to the cellular
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oxidative damage [4]. In addition, long-lived species also show low
rates of mitochondrial ROS generation and oxidative molecular
damage [4]. In this scenario, membrane phospholipids play a causal
role in aging and longevity by modulating oxidative stress and
molecular integrity.
In this critical review and hypothesis paper, a causal role for
membrane phospholipids unsaturation in the aging process is
proposed based on the available evidence relating membrane fatty
acid composition and lipoxidation-derived molecular damage with
the mitochondrial oxidative stress theory of aging and focused on
comparative and nutritional intervention models and the possible
underlying mechanisms involved.
2. Biological membranes and unsaturated fatty acids
Biological membranes are dynamic structures that generally
consist of bilayers of amphipathic molecules held together by non-
covalent bonds [5,6]. In eukaryotic cells, phospholipids are the
predominant membrane lipids and are, from a topographic point of
view, asymmetrically distributed across the bilayer [7–9]. Phospholi-
pids consist of a hydrophilic headgroupwith attachedhydrophobic acyl
chains. The variation in headgroups and aliphatic chains allows the
existence of more than 100 different phospholipids species in any
eukaryotic cell. Phosphatidylcholine, phosphatidylethanolamine, phos-
phatidylserine, phosphatidylinositol and cardiolipin, as well as sphin-
gomyelin and glycosphingolipids are the major phospholipids [5,6]. In
most eukaryotic membranes, phosphatidylcholine and phosphatidy-
lethanolamine represent together around 60–85% of the phospholipid
fraction, while for the other phospholipids small but signiﬁcant
differences can be found depending of the cell membrane and even
animal species [5,6,10–12]. Phospholipids play multiple roles. They
constitute a permeability barrier, modulate the functional properties of
membrane-associated activities, provide a matrix for the assembly and
function of a wide variety of catalytic processes, and act as donors
during the synthesis ofmacromolecules. Thewide range of processes in
which phospholipids are speciﬁcally involved explains the need for
diversity in phospholipid structures and fatty acid composition [13].
This diversity requires complex metabolic and regulatory pathways
[5,6]. In fact, for example, eukaryotic cells invest around 5% of their
genes to synthesize all of these lipids [10]. Themembrane phospholipid
composition is maintained primarily by feedback regulation of
phospholipid biosynthesis. Recent insights have emerged from the
study ofmembrane-bound transcription factors called sterol regulatory
element-binding protein (SREBP) that seem to monitor cell membrane
composition and to adjust lipid synthesis accordingly [14].
The acyl chains are either saturated, monounsaturated or poly-
unsaturated hydrocarbon chains that normally vary from 14 to 22
carbons in length [15]. In eukaryotic cells from vertebrate species, the
average chain length of a biological membrane is strictly maintained
around 18 carbon atoms, and the relative distribution between
saturated and unsaturated fatty acids follow a ratio 40:60, respec-
tively. Polyunsaturated fatty acids (PUFAs) are essential components
of cellular membranes in higher eukaryotes that strongly affect their
ﬂuidity, ﬂexibility and selective permeability. Additionally, PUFAs
affect many cellular and physiological processes in animals, including
modulation of ion channels and carriers, activities of membrane-
associated enzymes, regulation of gene expression, endocytosis/
exocytosis, cold adaptation and survival, and pathogen defence [15].
In vertebrates, C20 PUFAs are metabolized by oxygenases and other
enzymes to produce short-lived prostaglandins, leukotrienes and
thromboxanes that bind to speciﬁc G-protein-coupled receptors and
signal cellular responses that mediate vasodilation, blood pressure,
pain, fever, and inﬂammation, among others [6]. Polyunsaturated fatty
acids are generally synthesized by the modiﬁcation of saturated fatty
acid precursors that are products of fatty acid synthase. Thedesaturase enzymes, which are conserved across kingdoms, insert
double bonds at speciﬁc carbon atoms in the fatty acid chain and the
fatty acid elongation system elongates the precursors in two-carbon
increments [16]. The pathways for the synthesis of arachidonic acid
(20:4n-6, AA) and eicosapentaenoic acid (20:5n-3, EPA) involve
alternating fatty acid desaturation and elongation reactions that
have been characterized biochemically and are supported by the
cloning and characterization of desaturase and elongase genes. The
pathway to docosahexaenoic acid (22:6n-3, DHA) involves synthesis
and desaturation of 24:5n-3 followed by one cycle of β-oxidation in
the peroxisome [15,16]. The fatty acid desaturation pathway and the
deacylation–reacylation cycle are the mechanisms responsible for the
particular fatty acid composition of cell membranes.
In summary, life demands membranes. Membrane composition
(phospholipids classes' distribution and fatty acid proﬁle) is strictly
and dynamically regulated. The mechanisms of the homeostatic
regulation of the membrane composition, the mechanisms that create
lipid asymmetry and their functional implications, and the full
deﬁnition of the utility of the eukaryotic lipid repertoire are beginning
to be understood, being an exciting and rapidly expanding ﬁeld.
3. Membrane unsaturation and lipid peroxidation
As a principle, chemical reactions in living cells are under strict
enzyme control and conform to a tightly regulatedmetabolic program.
One of the attractors involved in biomolecular evolution is the
minimizing of unnecessary side reactions. Nevertheless, uncontrolled
and potentially deleterious reactions occur, even under physiological
conditions.
Reactive oxygen species express a variety of molecules and free
radicals (chemical species with one unpaired electron) physiologically
generated from the metabolism of molecular oxygen [17]. They are
extremely reactive and have damaging effects. Superoxide anion, the
product of a one-electron reduction of oxygen, is the precursor of most
ROS and a mediator in oxidative chain reactions. Dismutation of
superoxide anion (either spontaneously or through a reaction
catalyzed by superoxide dismutase enzymes) produces hydrogen
peroxide, which in turn may be fully reduced to water or in the
presence of ferrous or cuprous ions forms the highly reactive hydroxyl
radical. In addition, superoxide anion may react nonenzymatically
with other radicals including nitric oxide in a reaction controlled by
the rate of diffusion of both radicals. The product, peroxynitrite, is also
a very powerful oxidant. The oxidants derived from nitric oxide have
been called reactive nitrogen species (RONS). In living cells, the major
sites of physiological ROS generation are the complexes I and III of the
mitochondrial electron transport chain, which contains several redox
centers (ﬂavins, iron–sulfur clusters, and ubisemiquinone) capable of
transferring one electron to oxygen to form superoxide anion [3,4,18–
22]. Oxidative damage is a broad term used to cover the attack upon
biological molecules by free radicals. Reactive oxygen species attack/
damage all cellular constituents [17].
The susceptibility of membrane phospholipids to oxidative altera-
tions is related to two inherent traits, the physico-chemical properties
of the membrane bilayer and the chemical reactivity of the fatty acids
composing the membrane [23]. The ﬁrst property is related with the
fact that oxygen and free radicals are more soluble in the ﬂuid lipid
bilayer than in the aqueous solution. Thus, membranes contain an
interior organic phase, in which oxygen may tend to concentrate.
Therefore, these differences in solubility are important when
considering the availability of oxygen/free radicals for chemical
reactions inside living systems: organic regions may contain more
free radicals than aqueous regions [24,25] and, consequently,
membrane lipids become primary targets of oxidative damage.
The second property is related to the fact that PUFA residues of
phospholipids are extremely sensitive to oxidation. Every membrane
phospholipid contains an unsaturated fatty acid residue esteriﬁed to
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polyunsaturated and the presence of a methylene group between two
double bonds renders the fatty acid sensitive to ROS-induced damage,
their sensitivity to oxidation increasing exponentially as a function of
the number of double bonds per fatty acid molecule [26,27] (Fig. 1).
Consequently, the high concentration of PUFAs in phospholipids not
only makes them prime targets for reaction with oxidizing agents but
also enables them to participate in long free radical chain reactions.
Reactive free radicals can pull off hydrogen atoms from PUFA side
chains. A hydrogen atom (HU) has only one electron. This hydrogen is
bonded to a carbon in the fatty acid backbone by a covalent bond.
Hence, the carbon from which HU is abstracted now has an unpaired
electron (i.e it is a free radical). Polyunsaturated fatty acid side chains
(two or more double bonds) aremuchmore easily attacked by radicals
than are saturated (no double bonds) or monounsaturated (one
double bond) side chains. When CU radicals are generated in the
hydrophobic interior of membranes, their most likely fate is
combination with oxygen dissolved in the membrane. The resulting
peroxyl radical is highly reactive: it can attack membrane proteins and
oxidize adjacent polyunsaturated fatty acid side chains. So, the
reaction is repeated and the whole process continues in a free radical
chain reaction, generating lipid hydroperoxides [17,28,29]. Lipid
hydroperoxides are more hydrophilic than unperoxidized fatty acid
side chains. They try to migrate to the membrane surface to interact
with water, thus disrupting the membrane structure, altering ﬂuidity
and other functional properties and making the membrane leaky.
Lipid peroxidation generates hydroperoxides as well as endoper-
oxides, which undergo fragmentation to produce a broad range of
reactive intermediates called reactive carbonyl species (RCS) with three
to nine carbons in length, the most reactive being α,β-unsaturated
aldehydes [4-hydroxy-trans-2-nonenal (HNE) and acrolein], di-alde-
hydes [malondialdehyde (MDA) and glyoxal], and keto-aldehydes [4-
oxo-trans-2-nonenal (ONE) and isoketals] [29,30]. 2-Hydroxyheptanal
(2-HH) is another major aldehydic product of lipid peroxidation of
PUFAn-6,while 4-hydroxyhexenal (4-HHE) is generated ina lower yield.
Additionally, a number of other short chain aldehydes are produced
during lipid peroxidation through poorly understood mechanisms.
These carbonyl compounds, ubiquitously generated in biological
systems, have unique properties contrasted with free radicals. For
instance, comparedwith both ROS and RONS, reactive aldehydes have a
much longer half-life (i.e., minutes to hours instead of microseconds to
nanoseconds for most free radicals). Further, the non-charged structure
of aldehydes allows them to migrate with relative ease through
hydrophobic membranes and hydrophilic cytosolic media, thereby
extending themigration distance far from the production site. Based on
these features alone, these carbonyl compounds can be moreFig. 1. The relative susceptibilities of selected unsaturated fatty acids to peroxidation.
Data are from [26], and all were empirically determined as rates of oxygen
consumption. They are expressed relative to the rate for linoleic acid (18:2n-6) which
is arbitrarily given a value of 1.destructive than ROS/RONS and may have far-reaching damaging
effects on target sites within or outside membranes.
In this scenario, and with these premises, biological membranes – in
a clear adaptive response to the oxidative conditions inherent to aerobic
life – evolved by lessening the relative abundance of PUFAs highly
susceptible to oxidative damage—highly unsaturated fatty acids (higher
than 2 double bonds) are less abundant compared with saturated,
mono- and di-unsaturated fatty acids, obtaining a higher structural
stability and a lower susceptibility to oxidative damage [4,23].
In summary, highly unsaturated fatty acids of cellular membranes
are the macromolecules most susceptible to oxidative damage in cells,
and this sensitivity increases as a function of their number of double
bonds. In addition, the carbonyl compounds generated as lipid
peroxidation-derived end-products extend the membrane damage
to other cellular constituents.
4. Lipid peroxidation and lipoxidation-derived molecular damage:
targets
Carbonyl compounds react with nucleophilic groups in macro-
molecules like proteins, DNA, and aminophospholipids, among others,
resulting in their chemical, nonenzymatic, and irreversible modiﬁca-
tion and formation of a variety of adducts and cross-links collectively
named advanced lipoxidation end-products (ALEs) [31]. Thus, by
reacting with nucleophilic sites in proteins (belonging basically to Cys,
Lys, Arg, and His residues), carbonyl compounds generate ALE adducts
such as MDA-Lys, HNE-Lys, FDP-Lys, and S-carboxymethyl–cysteine;
and the cross-links glyoxal–lysine dimmer, and lysine–MDA–lysine,
among several others. The accumulation of MDA adducts on proteins
is also involved in the formation of lipofuscin. Thus, lipofuscin
becomes a nondegradable intralysosomal ﬂuorescent pigment formed
through lipoxidative reactions [32].
Lipid peroxidation-derived end-products can also react at the
exocyclic amino groups of deoxyguanosine, deoxyadenosine, and
deoxycytosine to form various alkylated products [33]. Guanine is,
however, the most commonly modiﬁed DNA base because of its high
nucleophilicity. Some common enals that cause DNA damage, analo-
gously to proteins, are MDA, HNE, and acrolein, among others. Thus, the
most common adducts arising from enals are exocyclic adducts such as
etheno adducts, and MDA-deoxyguanosine (M1dG). Finally, the amino
group of aminophospholipids can also react with carbonyl compounds
and to initiate some of the reactions occurring in proteins and DNA,
leading to the formation of adducts like MDA-phosphatidylethanola-
mine, and carboxymethyl-phosphatidylethanolamine [34].
In summary, lipoxidation-derived molecular damage is a natural
consequence of aerobic life (Fig. 2). ALEs induce the chemical, none-
nzymatic and irreversible modiﬁcation of cellular constituents, and they
are the evidence for the existence of a ‘lipoxidative stress’ in vivo.
Molecular modiﬁcation by lipoxidation-derived reactive carbonyl spe-
cies is little known. Current challenge is to establish the chemical
structure of thesemodiﬁcations and themechanisms for their formation,
and to identify what factors control the nature, selectivity, extent, and
irreversibility of the molecular modiﬁcation occurring in vivo.
5. Physiological steady-state levels of ALEs: cellular defence
mechanisms
Since cells continuously produce free radicals, oxidative stress
homeostasis can only be maintained if endogenous cellular antiox-
idants are present. A large battery of antioxidant defences, both
enzymatic and nonenzymatic, has been selected and conserved during
animal evolution [17,35]. An antioxidant can be deﬁned as “any
substance that, whenpresent at low concentrations compared to those
of an oxidizable substrate, signiﬁcantly delays or prevents oxidation of
that substrate”. An antioxidant reacts with and neutralizes an oxidant,
or regenerates other molecules capable of reacting with the oxidant.
Fig. 2. Aminophospholipid, protein and DNA damage resulting from aldehydic products of lipid peroxidation. Shown are examples of molecular adducts (advanced lipoxidation end-
products, ALEs) generated by the reactive carbonyl compound glyoxal.
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scavenger antioxidants that act in lipophilic environments of cells
[36]. The major scavenger inside membranes is D-α-tocopherol
(vitamin E). Most membranes are thought to contain approximately
one tocopherol molecule per thousand lipid molecules [37]. Vitamin E
acts on lipid peroxyl groups inside membrane bilayers, reducing them
to hydroperoxides, and thus inhibiting the propagation of the
peroxidative chain reaction [29]. It breaks the chain reaction of lipid
peroxidation but is itself converted to a radical during the process.
Vitamin E also reduces lipid alkoxyl radicals to lipid alcohols. Oxidized
vitamin E can be recycled back to its reduced form by ascorbate or
ubiquinone (coenzyme Q). Carotenoids quench singlet oxygen, and
interact with other ROS at physiological tissue oxygen partial
pressures. Ubiquinol, the reduced form of coenzymeQ, is an important
antioxidant [38]. It is a hydroquinone that is synthesized and present
in all cellular membranes and its antioxidant activity is exhibited
through scavenging of lipids radicals or reduction of vitamin E radical.
Regeneration of coenzyme Q is performed by reductases that use
NADPH or NADH as cofactors.
Protection of membranes is also achieved by additional complex
systemthat involves severalmechanisms: lipid repair, lipid replacement,
scavenging of lipoperoxidation-derived carbonyl compounds, and
degradation-removal of ALE-modiﬁed molecules [23]. The action of
chain-breaking antioxidants can result in the production of lipid
hydroperoxides. Some of these are metabolized by glutathione
peroxidase (GPX) antioxidant enzymes, which act on H2O2 and also on
free fatty acid hydroperoxides, reducing them to fatty acid alcohols.
However, the peroxidized fatty acids must be ﬁrst released from the
membrane lipids. A phospholipid hydroperoxide glutathioneperoxidase
(PHGPX) has also been described in some mammalian tissues and is
capable of acting on peroxidized fatty acid chains still esteriﬁed to
membrane phospholipids and is thus a very important antioxidant
defence for membranes in situ [39]. An important mechanism for
removing peroxidized lipids is membrane lipid remodelling. While the
enzyme PHGPX is important in removing peroxidized acyl chains fromphospholipids other enzymes are also involved in the continual
deacylation/reacylation of phospholipids and this turnover of mem-
brane acyl chains is very rapid. PhospholipaseA2 is an important enzyme
for removing acyl chains from phospholipids while acyltransferase and
transacylase enzymes are responsible for reacylation of phospholipids
[40]. Thus, for example, when isolated rat liver cells are subjected to
oxidative stress, lipid peroxidation is increased, however there is no
change in either the fatty acid composition of, or in the rate of acyl
turnover of membrane phospholipids. There is however a decrease in
the PUFA content of cellular triacylglycerols. It is suggested that rapid
constitutive recycling of membrane phospholipids rather than selective
in situ repair is responsible for eliminating peroxidized phospholipids,
with triacylglycerols providing a dynamic pool of undamaged PUFA for
phospholipid resynthesis [41]. Carbonyl compounds are, however,
generated during the lipid peroxidation cascade.
Most reactive carbonyl species are detoxiﬁed in multiple ways,
including, conjugation to glutathione (GSH), oxidation by aldehyde
dehydrogenases, or reduction by aldo-keto reductases [17,23,29,30,33].
Strongly electrophilic carbonyl compounds induce rapid and signiﬁcant
depletion of intracellular glutathione content, suggesting that this is an
important detoxiﬁcation mechanism. Once GSH is depleted, cells
exhibit an intracellular change in redox status and propagate an
oxidative stress response following their production. Reaction of α,β-
unsaturated aldehydeswith GSH canproceed in one of twoways-either
by nonenzymatic conjugation or through GSH transferase (GST)-
mediated conjugation to form Michael adducts. Glutathione-S-trans-
ferases (GSTs) are particularly involved in the detoxiﬁcation of highly
reactive intermediate aldehydes. GSTs belong to a supergene family of
multifunctional enzymes [42] and among the eight main classes of
human GSTs, those involved in carbonyl detoxiﬁcation include the
Alpha, Mu and Pi classes (GSTA, GSTM, and GSTP) being active against
a wide variety of carbonyl compounds and being their expression
tissue speciﬁc. GSTA4-4 is the principal GST responsible for meta-
bolism of most long chain α,β-unsaturated aldehydes, although many
GSTs may be involved in the metabolism of these molecules. Several
1253R. Pamplona / Biochimica et Biophysica Acta 1777 (2008) 1249–1262oxidoreductases also inactivate HNE and related aldehydes. Particu-
larly, detoxiﬁcation of HNE in this manner is accomplished by oxida-
tion or reduction of the aldehyde or by reduction of the 2,3-double
bond. Aldehyde dehydrogenase 3 (ALDH3) is responsible for the
conversion of HNE to 4-hydroxy-2-nonenoic acid, a noncytotoxic
molecule. Aldose reductase and aldo-keto reductase AKR1C1 efﬁ-
ciently reduce HNE to 1,4-dihydroxy-2-nonene. Reduction of the 2,3-
double bond of HNE is carried out by 15-oxoprostaglandin oxidore-
ductase, forming 4-hydroxynonanal. Recent reports suggest that
related molecules (e.g., ONE) are metabolized in a similar fashion.
Finally, natural detoxifying mechanisms to protect tissues from RCS
damage also include the cytosolic GSH-dependent glyoxalases, thiol-
and histidine-containing dipeptides, presumably acting as trapping
agents, and ascorbic acid.
If these metabolic pathways are compromised or overcome by
excessive aldehyde generation, reaction with DNA, proteins, and
aminophospholipids occurs, potentially leading to adverse alterations
in cellular homeostasis. Additional defences able to cope with the
modiﬁcations derived from the interaction between RCS and macro-
molecules have been developed by biological systems. Among them
the following ones may be mentioned: systems that degrade
lipoxidatively damaged proteins (e.g. the proteasome), and DNA repair
enzymes [17,33,43].
In summary, aerobic life demands antioxidant defences. Physiolo-
gical steady-state level of both RCS and ALEs results from the balance
of several cellular mechanisms and is species-tissue–cell type speciﬁc.
Variations in the steady-state levels of lipoxidatively-modiﬁed cellular
constituents in vivo are due to corresponding differences in rates of
oxidant generation, local RCS concentration, antioxidant defences,
removal and repair capacity, and susceptibility to oxidative modiﬁca-
tions, among others (Fig. 3).
6. Molecular and cellular effects and signaling properties of RCS
and ALEs
Reactive carbonyl species (RCS) generated during the lipid
peroxidation reactions exhibit awide range ofmolecular and biological
effects, ranging from protein, DNA, and phospholipid damage to
signaling pathway activation and/or alteration. The detailed mechan-
isms of ‘toxicity’ are, however, mostly unknown.
6.1. ALEs and molecular integrity
Lipoxidation reactions lead to structural and functional changes on
proteins [31,44] such as i) alterations in physico-chemical properties
(conformation, charge, hydrophobicity, elasticity, solubility, and
electrophoretic mobility, among others); ii) formation of intra- and
inter-molecular protein cross-links and aggregates; iii) decrease/
inhibition in enzyme activity; iv) alteration of protein degradation; v)
altered trafﬁcking and processing of proteins; vi) modiﬁcation ofFig. 3. Physiological steady-state level of ALEs results from the balance ofextracellular matrix properties and cell–matrix interactions; and vii)
stimulation of autoimmune response, among others.
These nonenzymatic protein modiﬁcations are spontaneous,
random, unprogrammed and uncatalyzed chemical reactions. In
addition, as a general rule, all proteins can be the target of reactive
carbonyl species. However, whether some key cellular or extracellular
molecules are preferential targets of these chemical modiﬁcations and
whether the extent of their modiﬁcation is sufﬁcient to explain
impaired cellular and tissue function are key questions. In this context,
the determination of the steady-state levels for given ALEs does not
allow us to discern if speciﬁc proteins are damaged. Is there pattern
selectivity in the main targets?, What are the speciﬁcally damaged
proteins?, Why are this protein pool (if any) modiﬁed? Few studies
have addressed these questions, although various speciﬁc proteins
have been detected by using 2DE-WB-MALDI-TOF analysis that are
modiﬁed by ALEs [44] such as aconitase, actin, adenine nucleotide
translocase, albumin, aldolase A, apolipoproteins, aspartate amino-
transferase, ATPsynthase, carbonic anhydrase II, collagen, alpha-
crystallin, alpha-enolase, GFAP, glyceraldehyde-3-phosphate dehy-
drogenase, HSP27, HSP60, phosphoglycerate kinase 1, proteasome,
SOD and other antioxidant enzymes, succinate dehydrogenase, alpha-
synuclein, and thioredoxin-1. Obviously, more studies are needed to
obtain a scenic view by tissues, organs, systems, species and markers
of the speciﬁcally affected proteins that allow us to evaluate
structural/functional factors shared by these proteins (if any) in
order to explain this “speciﬁcity”. RCS probably act in a random
fashion; however, the sensitivities and proximities of potential targets
differ. The factors that can affect selectivity of lipoxidative damage to
proteins could include the presence of a metal-binding site, molecular
conformation, rate of proteolysis, and relative abundance of amino
acid residues susceptible to lipoxidative reactions, among others.
The degradation of modiﬁed proteins by RCS deserves special
mention. Though proteasomal degradation is activated by oxidative
stress [43], ALE-modiﬁed proteins are poorly degraded by proteasome
and tend to inhibit the proteolytic activity [43]. In fact, the extensive
modiﬁcation of cellular proteins by 4-HNE and by the related carbonyl
compounds leads to the formation of protein aggregates that
accumulate in cells and are not degraded by the proteasome, likely
due to a direct inhibition of proteasome by oxidized and cross-linked
proteins, and by 4-HNE-modiﬁed proteins. Though themodiﬁcation of
proteasome is not observed at low ormoderate 4-HNE concentrations,
higher concentrations may directly form adducts which readily
inhibits the enzymatic activity of proteasome and contributes to the
accumulation of modiﬁed proteins [43].
DNA lipoxidative damage is present in the genome of healthy
humans and other animal species at biologically signiﬁcant levels
similar or even higher that oxidation markers sensu stricto. DNA
damage is mutagenic, carcinogenic, and with powerful effects on
signal transduction pathways [33,45]. Furthermore, they are efﬁcient
premutagenic lesions that induce mutations frequently detected inseveral cellular mechanisms and is species-tissue-cell type speciﬁc.
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correlate to alterations in cell cycle control and gene expression in
cultured cells. Thus, lipid peroxidation must be considered a
signiﬁcant endogenous source of DNA damage and mutations.
Finally, the amino group of aminophospholipids can also react with
carbonyl compounds and to initiate some of the reactions occurring in
proteins, expanding the negative biological effects of this none-
nzymatic modiﬁcation [34]. Biological processes involving aminopho-
spholipids could be potentially affected by this process. Among these
processes, it may be highlighted i) asymmetrical distribution of
aminophospholipids in cellular and different subcellular membranes;
ii) translocation between and lateral diffusion in the membrane; iii)
membrane physical properties; iv) biosynthesis and turnover of
membrane phospholipids; and v) activity of membrane-bound
proteins that require aminophospholipids for their function [34].
In summary, themolecular integrity of proteins, DNA and aminopho-
spholipids can be altered as a consequence of a lipoxidative stress that, in
turn, can have awide range of downstream functional consequences and
maybe the causeof subsequentcellulardysfunctionsandtissuedamages.
6.2. Cellular adaptive response signaling to RCS
As mentioned above, the peroxidation of the PUFA chains of
phospholipids generates a complex mixture of carbonyl compounds.
Initially, these aldehydes were believed to produce only “cytotoxic”
effects associated with oxidative stress, but evidence is increasing that
these compounds can also have speciﬁc signaling roles inducing
adaptive responses driven to decrease oxidative damage and improve
antioxidant defences.
6.2.1. Cardiolipin oxidation, RCSs and uncoupling proteins: regulatory
role in mitochondrial free radical production
Cardiolipin, a phospholipid of unusual structure localized almost
exclusively within the inner mitochondrial membrane, is particularly
rich in unsaturated fatty acids. This phospholipid plays an important
role in mitochondrial bioenergetics by inﬂuencing the activity of key
mitochondrial inner membrane proteins, including several anion
carriers and electron transport complexes I, III and IV [46].
Mitochondrial cardiolipin molecules are possible targets of oxygen
free radical attack, due to their high content of polyunsaturated fatty
acids and because of their location in the inner mitochondrial
membrane near to the site of ROS production. In this regard, it has
been recently demonstrated that mitochondrial-mediated ROS gen-
eration affects the activity of complex I, as well as complexes III and IV,
via peroxidation of cardiolipin following oxyradical attack to its fatty
acid constituents [47]. These ﬁndings might explain, at least partially,
the decline in respiratory chain complexes observed in mitochondria
isolated from aged animals and in pathophysiological conditions that
are characterized by an increase in the basal rate of the ROS
production. So, cardiolipin integrity plays an important role determin-
ing the rate of ROS generation by mitochondrial complexes I and III.
Available studies support the notion that superoxide radical
produced by the electron transport chain can cause mild uncoupling
of mitochondria by activating the membrane proton conductance by
uncoupling proteins (UCPs; [19,22]). Insight into the mechanism by
which superoxide radical activates UCPs comes from the ﬁnding that
the lipid peroxidation product 4-HNE and its homologs induce
uncoupling of mitochondria through UCP1, UCP2, and UCP3 and also
through the adenine nucleotide translocase [48]. This and other
observations support a model in which endogenous superoxide
production generates carbon-centered radicals that initiate lipid
peroxidation, producing alkenals like 4-HNE that may activate UCPs
and adenine nucleotide translocase. While the thermogenic function
of UCP1 has been well characterized, a function for its homologs
(UCP2, UCP3, avian UCP, and plant UCP) has yet to be unambiguously
deﬁned. A possible physiological function for UCPs has been proposed[48]. In this model, UCPs respond to overproduction of matrix
superoxide by catalyzing mild uncoupling, which lowers proton
motive force and would decrease superoxide production by the
electron transport chain. This will attenuate superoxide-mediated
molecular damage [49], at the cost of a slightly lowered efﬁciency of
oxidative phosphorylation. It was hypothesized that this negative
feedback loop will protect cells from ROS-induced damage and might
represent the ancestral function of all UCPs [19].
6.2.2. Antioxidant response signaling
Reactive carbonyl species can activate the ‘antioxidant response’
likely to prevent their accumulation to toxic levels [50,51]. This
signaling cascade culminates in the nuclear translocation of and
transactivation by the transcription factor Nrf2, the master regulator
of the response [52]. Nrf2 activity is repressed by an inhibitory
binding protein, Keap1. Keap1 retains Nrf2 in the cytosol, closely
associated with the actin cytoskeleton, and promotes proteasomal
degradation of Nrf2 through Cullin3-dependent polyubiquitination.
Following exposure to RCS, Keap1 can be directly modiﬁed on several
cysteine residues, and this modiﬁcation can promote release of Nrf2.
Intracellular modiﬁcation of Keap1 similarly allows for increased
stabilization and nuclear localization of Nrf2, potentially through
direct modiﬁcation of Keap1 coupled with Keap1 ubiquitination and
degradation. Nrf2 contains a C-terminal basic leucine zipper structure
that facilitates dimerisation and DNA binding, speciﬁcally to the
antioxidant response element (ARE). The binding of Nrf2 to the ARE,
which requires heterodimerisation with small Maf proteins, stimu-
lates transcription of downstream genes, in part, by recruiting tran-
scriptional co-activators, particularly CREB-binding protein (CBP)
through the Neh4 and Neh5 domains of the transcriptional factor.
Nrf2 activity is also enhanced through phosphorylation by several
kinases, including protein kinase C isoforms and the ER-stress res-
ponsive kinase PERK. The Nrf2-regulated cytoprotective genes are
[52]: aldo-keto reductases (AKR), glutamate cysteine ligase [catalytic
subunit (GCLc), and regulatory subunit (GCLm)], glutathione-S-
transferase (GST), glutathione synthetase (GS), heme-oxygenase 1
(HO-1), metallothionein, microsomal epoxide hydrolase (mEH), NAD
(P)H:quinine oxireductases (NQO), peroxiredoxin 1 (Prx1), superoxide
dismutases (SOD), thioredoxin reductases (TrxR), thioredoxins (Trx),
and UDP-glucuronosyltransferases (UGT). The mechanism(s) by
which carbonyl compounds activate the antioxidant response
element (ARE) through the Nrf2 transcription factor is currently
under investigation.
6.2.3. Heat-shock response signaling
Exposure of cells to environmental and physiological stress leads to
an imbalance in protein metabolism, which challenges the cell to
respond rapidly and precisely to the deleterious effects of stress on
protein homoeostasis. The heat-shock response, through activation of
heat-shock transcription factors (HSFs) and the elevated expression of
heat-shock proteins and molecular chaperones, protects the cell
against the accumulation of non-native proteins [53].The heat-shock
response is stimulated by endogenous oxidants and lipid peroxidation
products alike [53,54]. Activation of heat-shock factor-1 (HSF1) during
this process subsequently induces the expression of a variety of heat-
shock proteins (Hsps). HSF1, like Nrf2, resides predominantly in the
cytosol under basal conditions, where it is bound and inhibited by
various Hsps, including Hsp90, Hsp70, and Hsp40. Following extensive
protein damage by RCS, Hsps are recruited to sites of protein damage
and therefore release HSF1, thereby promoting its activation. This
sequence of events allows HSF1 to migrate into the nucleus, and
stimulate transcription of Hsp genes. HSF1 regulation is also redox
sensitive, with its activation potentially requiring formation of a
disulﬁde bond. When active, trimeric HSF1 binds to DNA in the
promoters of numerous Hsp genes, giving rise to downstream effects
that inﬂuence both protein folding homeostasis and cell death.
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the best understood regarding its regulation of signaling and cell
death pathways [53]. In addition to its function of promoting refolding
or clearance of misfolded or aggregated proteins, Hsp70 prevents
apoptosis through disruption of apoptosome formation, potentially
through directly binding Apaf1. An additional mode through which
Hsp70 potentially inhibits cell death is by blocking stress-responsive
mitogen-activated protein kinase (MAPK) signaling. Therefore, spe-
ciﬁc Hsp70 isoforms induced in stressed cells following HSF1
activation may function as negative regulators of apoptotic signaling
in multiple ways.
6.3. Cellular damaging effects of RCS
6.3.1. Modiﬁcation of tyrosine kinase receptors and cell cycle
4-HNE added to cultured cells exhibits a dose-dependent effect. So,
physiological concentration of 4-HNE has growth-regulating effect,
whereas higher concentration is primarily cytotoxic [55,56]. 4-HNE
added to the culture medium induces both modiﬁcation and dysfunc-
tion of tyrosine kinase receptors (TKRs) such as epidermal growth
factor receptor (EGFR) and platelet-derived growth factor receptor
(PDGFR) in a biphasic manner. 4-HNE, at physiological and moderate
concentrations (b1 μM and 1–10 μM, respectively) triggers a sustained
activation of TKRs EGFR and PDGFR [57,58]. The mechanism of TKRs
activation involves the formation of 4-HNE adducts on the receptor,
which triggers TKR autophosphorylation and the activation of the
downstream signaling pathway, extracellular signal-regulated kinase
(ERK)1/2 phosphorylation and cell cycle progression [57,58]. So, at
physiological concentrations, 4-HNE can act as a growth factor and
promotes cell proliferation. However, high concentrations of 4-HNE
inhibit cell proliferationmediated bygrowth factor receptors EGFR and
PDGFR, though a two-fold increase of the c-fos mRNA level was
observed as a protective but abortive stress-induced response. This
inhibitory effect of 4-HNE on growth factor-mediated cell proliferation
is in agreement with the progressive desensitization of PDGFR to its
own ligand PDGF-BB, observed in smooth muscle cell in prolonged
contact with 4-HNE (at concentrations N10 μM). Inhibition of cell cycle
progression, reported in leukaemic cells, is mediated by a decrease in
expression of cyclin D1, D2 and A and an increase in the expression of
the cycline kinase inhibitor p21, thereby inducing an accumulation of
cells in the G0/G1 phase of the cell cycle [59]. 4-HNE induces an
accumulation of the hypophosphorylated form of the retinoblastoma
tumor suppressor gene product hyperphosphorylated retinoblastoma,
which binds and inactivates the E2F transcription factors, represses the
transcription and induces cell cycle arrest. Moreover, 4-HNE inhibits
the expression of the protooncogene c-myc in HL-60, without affecting
the expression of c-fos. Higher toxic concentrations of 4-HNE (50 μM)
enhanced c-fos transcriptionwhile cell proliferation is inhibited. These
biological effects are not restricted to 4-HNE, since other carbonyl
compounds such as methylglyoxal and glyoxal are also able to inhibit
various RTKs, including EGFR, PDGFR and insulin receptor [60,61].
6.3.2. NF-κB
The proinﬂammatory transcription factor NF-κB (nuclear factor-
κB) is a direct regulator of proinﬂammatory and antiinﬂammatory
genes, cell survival and proliferation [62]. The activation of NF-κB
requires the phosphorylation of its inhibitor κB (IκB), which is
necessary for its degradation by the ubiquitin–proteasome pathway.
4-HNE and acrolein inhibit the activation of NF-κB, either via a direct
inhibitory effect on proteasome or through the inhibition of an
upstream step required for the phosphorylation of IκB as reported in
human monocytic cells, in which 4-HNE inhibits the activation of NF-
κB induced by lipopolysaccharide, interleukin-1β and phorbol ester
[63]. Conversely, 4-HNE prevents the activation of NF-κB elicited by
Chlamydia pneumoniae by inhibiting the phosphorylation of IκB and
its subsequent proteolysis [64]. A potential mechanism has beenproposed recently [65] by reporting that the inhibition of interferon-α
(TNF α)-induced activation by acrolein could be due to the modiﬁca-
tion of IKK-subunit by acrolein. In contrast, aldehydes may induce
inﬂammation via an activation of NF-κB, as shown for 4-HHE that
activates NF-κB via the IκB kinase/NF-κB inducing kinase pathway.
This mechanism involves an upstream activation of p38 MAPK and
ERK1/2 kinase [66]. Finally, it has recently been described a clear
proinﬂammatory effect for ALEs in monocytes [67].
6.3.3. Apoptosis signaling
High concentrations of 4-HNE or acrolein (N20 μM) are highly toxic
for most cell types (reviewed in [33,56]). The mechanism of apoptosis
elicited by RCS involves various effects, including signaling or protein
modiﬁcation. The activation of JNK has been particularly investigated
in the antiproliferative and apoptotic effect of 4HNE [68]. This JNK
pathway plays amajor role in the cooperative apoptotic effect of tissue
growth factor β-1 (TGFβ-1) and 4-HNE on colon cancer cell lines. Both
acrolein and 4-HNE increase the levels of the phosphorylated form of
transcription factors c-jun (which promotes apoptosis) and CRE-
binding protein (CREB) (involved in survival), but decrease the activity
of the CREB-responsive promoters (while increasing c-jun responsive
promoter), which contributes to neuron degeneration and apoptosis.
Methylglyoxal and glyoxal are pro-apoptotic through mechanisms
involving calcium deregulation, GSH depletion, oxidative stress, and
the activation of stress kinases p38 and JNK. 4-HNE increases the
mRNA and protein expression of the pro-apoptotic adaptors/regula-
tors FasR, FasL, Bax, and caspases-1, -2, -3 and -8. In human lens
cultured cells (HLE B-3), 4-HNE adducts are correlated with the
induction of Fas, the activation of JNK and caspase 3, while the
transfection of the α-class GST mGSTA4a (which neutralizes 4-HNE)
inhibits Fas expression. The mechanism of cell death evoked by these
aldehydes could also involve the generation of peroxynitrite, as
reported for 4-HHE and for methylglyoxal.
4-HNE impairs the mitochondrial function, via the alteration of
GSH metabolism and the induction of massive mitochondrial
oxidative stress. More speciﬁcally, moderately elevated concentra-
tions of 4-HNE or very low doses of 4-HHE trigger a calcium-mediated
induction of the mitochondrial transition pore. In addition, in vitro
experiments on isolated mitochondria or reconstituted models for the
adenine nucleotide translocator pretreated with 4-HNE or 4-HHE
indicate that the modiﬁcation of ANT by these aldehydes impairs its
function and activity. Lastly, 4-HNE alters mitochondrial calcium
uptake and cytosolic calcium homoeostasis, which results in necrosis
or apoptosis. This mechanism is involved in neuronal cell death.
7. Membrane unsaturation, RCS, ALEs, and the physiological aging
process
The loss-of-function and structural integrity of ALE-modiﬁed
biomolecules have a wide range of downstream functional con-
sequences and is the cause of subsequent cellular dysfunctions and
tissue damage. Many evidence suggests a role for membrane
unsaturation, RCS generation, and ALEs formation in aging and
longevity based on: i) its accumulation with aging in several tissues
and species; ii) physiological interventions (dietary restriction) that
increase longevity, attenuate age-related changes in membrane
unsaturation and lipoxidative damage; iii) the longer the longevity
of a species, the lower is the membrane unsaturation and lipoxida-
tion-derived molecular damage; and ﬁnally iv) exacerbated levels of
ALEs are associated with pathological states. Comprehensive reviews
on this last point have recently been published [30,33,56].
7.1. Membranes and aging
The singular importance of membrane unsaturation in the aging
process is highlighted by studies showing i) Age-related changes in
Table 1
Effect of aging on membrane lipid parameters in tissues from different animal species
Marker/parameter Tissue Species Change with aging References
Membrane fatty acid composition
PI⁎/PUFA content Whole Drosophila ↑ #
Liver Rat ↑ [71–73]
Liver microsomes and mitochondria Rat ↑ or = [74–78]
Kidney microsomes and mitochondria Rat ↑ [78]
Heart Rat ↑ [73]
Heart mitochondria Rat ↑ or = [79,80]
Brain synaptosomes Rat ↓ [81]
Cerebral cortex Rat ↓ [82]
Membrane lipid peroxidation
Lipofuscin Liver Mouse, human ↑ [83–85]
Brain Mouse, rat ↑ [84–88]
Testis Mouse, rat ↑ [88,89]
Heart Mouse, rat, dog ↑ [84,87–92]
Adrenal cortex Rat ↑ [88]
Kidney Rat ↑ [88]
MDA-TBARS Liver Mouse, rat ↑ [72,84,93,94]
Liver microsomes and mitochondria Rat ↑ [76,94–96]
Heart Rat ↑ [94]
Heart mitochondria Rat ↑ [97]
Brain and Brain regions Rat ↑ [94,98]
Plasma, splenic lymphocytes Rat ↑ [99]
Lipid hydroperoxides Liver Rat ↑ [72]
Liver microsomes and mitochondria Rat ↑ [76]
Conjugated double bonds Heart mitochondria Rat ↑ [97]
Expired hydrocarbons1 Whole animal Rat, human ↑ [100–102]
Membrane order parameters
Membrane ﬂuidity Liver Rat ↓ [94,107]
Liver mitochondria and microsomes Rat ↓ [103,104]
Brain Rat ↓ [82,94,105,107]
Brain mitochondria and synaptosomes Rat ↓ [105,106]
Heart Rat ↓ [94,107]
Heart mitochondria Rat ↓ [79]
⁎PI, Peroxidizability index: calculated from fatty acid compositional analysis; PUFA: Polyunsaturated fatty acid content.; MDA-TBARS, malondialdehyde determined by thiobarbituric
acid reactive substances method; #, unpublished results; 1, expired hydrocarbons: pentane and others.
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in double bond and peroxidizability indexes and in vivo and in vitro
lipid peroxidation during aging in an organ-dependent way (table 1).
This is mainly due to decreases in the less unsaturated linoleic and
linolenic acids and to increases in the highly unsaturated arachidonic
acid, and docosotetra- penta- and -hexaenoic acids. An important
exception, in the contrary sense, is the brain; iii) Increases in the
amount ethane and pentane in exhaled air (Table 1); iv) Increases in
the lipoxidation-derived protein and DNA damage with age (Table 2);
and v) The senescent accelerated prone mouse (SAM-P) has higher
levels of the very unsaturated arachidonic (AA) and docosahexaenoic
(DHA) acids and peroxidizability index and lower levels of linoleic acid
than SAM-resistant controls [69,70].
Additional observations suggesting that membrane unsaturation is
related to aging include data showing that strongly unsaturated fatty
acids like AA and DHA can have detrimental effects in vivo (reviewed
in [3,4]). Examples of this include decreases in respiratory control and
increases in proton leak in mitochondria, increased mitochondrial
breakage and dysfunction, peroxisome proliferation, fatal ventricular
ﬁbrillation in rats, neurological damage, increased lipid peroxidation
in associationwith various diseases, increased incidence of death from
apoplexy, or sudden cardiac death in humans induced by AA or DHA.
Increases of more than one order of magnitude in AA (to 500 μM)
occur in the brain during ischemia and even concentrations of AA and
eicosapentaenoic acid (20:5n-3) in the much lower 20–40 μM range
uncouple mitochondria and cause tissue edema. Hypermetabolic
uncoupling effects of thyroid hormones on rat liver mitochondria are
due to a great extent to increased AA/LA ratios caused by increases in
desaturase activities induced by the hormone, whereas LA is
considered a “proton plug” or coupler. Furthermore, the largestamounts of unsaturated fats in the healthy human diet must be
present as fatty acids with low degrees of unsaturation like oleic acid
and LA, whereas beneﬁcial levels of dietary n-3 PUFAs (the n-3
“paradox”) occur only at the low (1%) optimum dietary levels
recommended by the World Health Organization. These beneﬁcial
effects are probably observed because the conversion of dietary
linolenic acid to highly unsaturated fatty acids like DHA is strongly
limited thanks to the constitutively low delta-5/-6 desaturase
activities of humans. In this context, two studies deserve special
attention: a) Inuits are human populations showing unusually low
incidence of coronary heart disease, psoriasis, rheumatoid arthritis
and asthma and have very low levels of AA in plasma phospholipids
due to a genetic abnormality in essential fatty acid desaturationwhich
persists even after changing them to a LA-rich diet [123]; and b) in a
recent prospective study on old healthy subjects, it was found that a
higher monounsaturated fatty acid intake (Mediterranean diet)
increased survival, while a higher unsaturated/saturated fatty acid
ratio increased total mortality [124].
7.2. Membranes and aging: effects of dietary and pharmacological
interventions, and genetic manipulations
Are experimental extensions in mean and maximum longevity
accompanied by attenuations of membrane unsaturation and lipox-
idation-derived molecular damage? This question is a key issue that
goes beyond correlation to establish a causative role for membranes
and lipoxidative stress in aging. In the performed studies, investigators
either fed animals antioxidants or genetically altered the expression of
antioxidant enzymes tomodify the ﬂux of free radicals in cells thereby
altering oxidative damage to biomolecules. Unfortunately, in most
Table 2
Effect of aging on steady-state levels of lipoxidative protein and DNA modiﬁcations in










Lens protein Human ↑ [113,114]
Urine Human ↑ [115]
Liver mitochondria Rat ↑ [75,116]
Serum Rat ↑ [117]
Aorta Rat ↑ [117]
Heart Rat ↑ [117]
GOLD Lens protein Human ↑ [118,119]
MDAL Liver Rat ↑ [73]
Liver mitochondria Rat ↑ [75]
Heart Rat ↑ [73]
Cerebral cortex Human ↑ (#)
HNE-protein Heart Rat ↑ [120]
MDA-DNA Liver Rat ↑ [45,121]
Kidney Rat ↑ [121]
Testes Rat = [121]
Brain Rat ↑ [121,122]
CML, Carboxymethyl-lysine; GOLD, Glyoxal lysine dimer; HNE-protein, hydroxynonenal-
protein (cysteine, lysine, or histidine); MDAL, Malondialdehyde-lysine; MDA-DNA,
malondialdehyde-DNA. (#) Unpublished results.
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determined whether the manipulation, either pharmacological or
genetic, altered the levels of lipoxidatively damaged proteins and DNA
that accumulate with age.
Caloric restricted (CR) rodents were the only experimental
manipulation known to increase longevity, until 1987 when it was
observed that mutations in Caenorhabditis elegans and later muta-
tions in Drosophila melanogaster could give rise to long-lived mutants
[125–127]. CR, in which rodents are fed 60–70% of the food
consumed by pair-fed rodents fed ad libitum, has been shown to
delay or reduce the onset of most age-related diseases and alter most
physiological processes that change with age [128]. Because the
increase in longevity (both mean and maximum longevity) occurs
with retardation in disease and physiological decline, it has been
argued that CR increases the survival by modulating the basic mecha-
nisms underlying the aging process. At the present time, several
evidences seem to suggest that CR might delay aging and extend
longevity through mechanisms that involve changes in the lipoxi-
dative status.
Caloric, as well as protein and methionine restriction – nutritional
interventions that increase longevity – attenuates age-related changes
in the degree of membrane unsaturation and the level of lipoxidation-
derived protein damage in a variety of tissues and animal species
[96,129] (Table 3). Thus, a decrease in lipid peroxidation and
lipoxidation-derived protein damage has been reported in CR ﬂies
(Drosophila; Pamplona et al., unpublished results), and tissues (liverTable 3
Effect of caloric- protein- and methionine restriction on membrane unsaturation and advan
Specie Tissue DR type (%) DR duration
Rat Liver mitochondria 8.5% CR 7 weeks
Rat Liver mitochondria 25% CR 7 weeks
Rat Heart mitochondria 40% CR 4 months
Rat Heart mitochondria 40% CR 1 year
Rat Liver mitochondria 40% CR 4–24 months
Rat Liver 40% CR 6 weeks
Rat Liver 40% PR 7 weeks
Rat Liver mitochondria 40% MetR 7 weeks
Rat Liver mitochondria 80% MetR 7 weeks
Rat Heart mitochondria 80% MetR 7 weeks
Rat Brain 80% MetR 7 weeksand heart) from rats and mice [75,76,80,96,130–136]. CR has also been
shown to reduce levels of lipofuscin in tissues of rodents and C.
elegans [23,32,84,87,137,138], as well as to decrease oxidative damage
to mitochondrial DNA as measured by the levels of oxo8dG (reviewed
in [3]). No data are available for DNA damaged by carbonyl
compounds. The magnitude of the change is lower for membrane
unsaturation (between 2.5 and 10%) than that for the lipoxidation-
derived molecular damage (between 20 and 40%) likely due to the
added effect of the lower mitochondrial free radical generation also
induced by these nutritional interventions. In addition to the
moderate but signiﬁcant effect on membrane unsaturation, these
nutritional interventions show an effect that is directly related to the
percent of the dietary restriction applied, being both protein and
methionine restriction even more intense and effective that caloric
restriction. The effects of CR on membrane unsaturation could be
divided in three stages depending of CR duration in rats. During short-
term CR periods, decreases in the rate of mitochondrial ROS
production and lipoxidation-derived protein damage are observed in
some tissues together with minor changes in membrane fatty acid
composition. If CR is applied for several weeks–months, changes in
particular fatty acids with moderate or no changes in double bond
content occur, although the magnitude of the changes depends on the
organ and the intensity of the restriction. Finally, in long-term CR, the
beneﬁcial effects on ROS production, DBI-fatty acid composition, and
lipoxidation-derived protein damage are evident. In fact, CR
diminishes the slope of the relationship between age and age-related
lipid peroxidation. Thus, the CR manipulation seems to trigger an
adaptive response protecting the most basic requirements of
membrane integrity.
Antioxidants, although possibly involved in protection against
various age-related diseases, do not seem to control the rate of aging
[3,4,20,22]. There are four lines of evidence for this. First, contrary to
early hypotheses, it is now well known that the endogenous levels of
antioxidants in tissues including the brain do not decrease during
aging. Second, it is possible that the slow rate of aging of long-lived
animals could be due to a constitutively higher antioxidant defence
system. Surprisingly, when this was analyzed the reverse was found.
Most studies showed that the levels of antioxidant enzymes and low-
molecular-weight antioxidants in tissues correlate inversely with the
species-speciﬁc longevity of vertebrates. Thus, it may be inferred that
a low antioxidant levels of long-lived animals predict that their rate of
ROS generation in vivo must also be low (and lower than that of short-
lived animals), otherwise they could not maintain a level of oxidative
stress homeostasis compatible with its rate of aging. The third source
of information is studies in mammals in which levels of antioxidants
are experimentally increased through dietary supplementation,
pharmacological induction or transgenic techniques. The outcome of
almost all such investigations is that maximum longevity remains
unaffected. This is consistent with investigations performed in
invertebrate models. Finally, the fourth line of evidence comes from
studies in which genes encoding particular antioxidants are knockedced lipoxidation end-products (ALEs) of different rat tissues












1258 R. Pamplona / Biochimica et Biophysica Acta 1777 (2008) 1249–1262out: the resulting animals can show different pathologies but their
aging rates do not seem to be affected. Increased mean longevity is a
much more frequent ﬁnding than increased maximum longevity in
antioxidant treated or antioxidant-induced animals. Consequently,
the broad lack of effect of antioxidants on longevity indicates that they
do not slow down the endogenous aging process.
Finally, one of essential tools in studying the biological mechanism
(s) underlying aging are animal models that show alterations in aging,
most importantly, models that show retarded aging. The discovery in
1987 that chemical induced mutations in C. elegans lead to a mutant,
age-1, with increased longevity [125] has led to the discovery of a large
number of loss-of-function mutants in C. elegans and Drosophila that
are shown to increase longevity [127]. The studies with mutant
invertebrates have led investigators to question whether similar
mutations in mammalian systems would also lead to retarded aging
and increased longevity. Until recently, the only mammalian model of
retarded aging was caloric restriction. However, over the past ten
years, mutant models of mice have been reported that have a
signiﬁcant increase in longevity compared to wild-type controls.
Globally, the studies with S. cerevisiae, like the studies with C. elegans,
Drosophila and mice, indicate a link between increased longevity and
resistance to oxidative stress [3,22,44]. However, the physiological
mechanism whereby increased resistance to stress, including oxida-
tive stress, leads to increased longevity has not been identiﬁed. It is
generally assumed that the increased resistance to oxidative stress
would lead to a reduced age-related accumulation in oxidative
damage. Therefore, it is too early to conclude that most of these
manipulations have increased longevity by retarding the accumula-
tion of lipo- and oxidative damage during aging.
In summary, studies comparing constitutive antioxidant levels in
both vertebrates and invertebrates' species, and experiments increas-
ing or decreasing their tissue antioxidant concentrations in different
ways, consistently indicate that antioxidants do not seemcontrol aging
rate, although they can protect against different pathologies and early
death. The discovery and design of new mitochondrial antioxidant
defences and new strategies of antioxidant over-expression will offer
us more solid and deﬁnitive conclusions.
7.3. Membranes and longevity
Lipid oxidation is one of the natural consequences of aerobic life.
The high concentration of PUFAs in cellular membrane phospholipids
not only makes them prime targets for reaction with oxidizing agents
but also enables them to participate in long free radical chain
reactions. With these premises, and maintaining other physiologicalTable 4
Comparative studies of membrane unsaturation in animal species with different maximum
Species compared Maximum longevity (years) Organ
Rat–pigeon–human 4–120 mtLiver
Rat vs pigeon 4, 35 mtLiver
Rat vs pigeon 4, 35 mtHeart
8 mammals 3.5–46 mtLiver
Rat vs pigeon 4, 35 mtHeart
8 mammals 3.5–46 Heart
Mouse vs canary 3.5, 24 Heart
Mouse vs parakeet 3.5, 21 Heart
7 mammals 3.5–46 Liver
8 mammals 3.5, 46 mtLiver
11 mammals+9 birds 3.5–120 Skeletal
9 mammals+8 birds 3.5–120 mtLiver
Rat vs pigeon 4, 35 Skeletal
Mouse, parakeet, canary 3.5, 21, 24 Brain
8 mammals 3.5–46 Heart
SAM-R/1 vs SAM-P/1 mice 1.8, 1.2 Liver
Strains of mice (Idaho, Majuro and WT) 3.97, 3.58, 3.35 Skeletal
Mice vs naked mole-rats 3–4, 28 mtSkele
Queen honey bees vs workers 2–5, 75–135 days Head, thproperties, a low degree of fatty acid unsaturation in cellular
membranes may be advantageous by decreasing their sensitivity to
lipid peroxidation. This would also protect other molecules against
lipoxidation-derived damage. Thus, it has been found that long-lived
animals (birds and mammals, including humans) have a lower degree
of total tissue and mitochondrial fatty acid unsaturation (low Double
Bond Index, DBI, and Peroxidizability Index, PI) than short-lived ones
[3,4,18,20,22,23,35,129] (Table 4). In agreement with this, it has been
demonstrated that in long-lived animal species a low degree of total
tissue and mitochondrial fatty acid unsaturation is accompanied by a
low sensitivity to in vivo and in vitro lipid peroxidation and a low
steady-state level of lipoxidation-derived adducts in both tissue and
mitochondrial proteins from organs like the skeletal muscle, heart,
liver, and brain (Table 4). In this line, lipofuscin, often considered a
hallmark of aging also shows an accumulation rate that inversely
correlates with longevity [32]. These ﬁndingswere consistent with the
negative correlation observed between maximum longevity and the
sensitivity to lipid autoxidation of mammalian kidney and brain
homogenates [156]. Whilemaximum longevity can differ dramatically
between mammal and bird species, there can also be signiﬁcant
lifespan differences within a species. For example, populations of two
wild-derived strains of mice display extended longevity (both mean
and maximum longevity) compared to genetically heterogenous
laboratory mice when kept under identical conditions [157]. The PI
of skeletal muscle phospholipids and liver phospholipids of the two
wild-type mice strains with the extended longevity was signiﬁcantly
smaller than that of the laboratory mice [153]. This is interesting
because, since the different mice strains were fed the same diet, it
shows that the differences inmembrane composition between species
are not determined by dietary differences but is genetically controlled.
It is also interesting that in the senescence-accelerated mouse (SAM)
strain, the SAM-prone mice have greater levels of the highly
polyunsaturated peroxidation-prone fatty acids 22:6n-3 and 20:4n-6
and lower levels of the less peroxidation-prone 18:2n-6 PUFA in their
membranes, and consequently have a greater PI than the SAM-
resistantmice [69]. SAM-pronemice also showgreater degrees of lipid
peroxides in their tissues than do SAM-resistant mice. Finally, naked
mole-rats are mouse-sized and are the longest-living rodents known,
with a recorded MLSP exceeding 28 years [158]. When membrane
fatty acid compositionwas measured in tissues from naked mole-rats,
it was found that they have very low levels of 22:6n-3 in their tissue
phospholipids compared to mice. Although both mice and naked
mole-rats have similar levels of total unsaturated fatty acids in their
tissue phospholipids, the low 22:6n-3 levels of the naked mole-rats
result in lower PI and more peroxidation-resistant membranes inlongevities
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degree of unsaturation of cellular membranes is a general character-
istic of long-lived vertebrate homeotherms, both birds and mammals.
The occurrence of correlation does not necessarily mean that a
cause-effect relationship is operative. In order to clarify whether the
low membrane unsaturation of long-lived animals protects their
mitochondria from lipid oxidation and lipoxidation-derived protein
modiﬁcation, studies of experimental dietary modiﬁcation of in vivo
membrane fatty acid unsaturation have been performed. These
studies were specially designed to partially circumvent the homeo-
static system of compensation of dietary-induced changes in
membrane unsaturation which operates at tissue level. The obtained
ﬁndings suggest that lowering the membrane unsaturation of cellular
membranes protects post-mitotic tissues against lipid peroxidation
and lipoxidation-derived macromolecular damage [159–161].
Themembrane acyl composition of themammals and birds studied
indicates that their biological membranes maintain an identical fatty
acid average chain length (18 carbon atoms), a similar ratio of saturated
versus unsaturated fatty acids (ratio 40:60), and a similar phospholipid
distribution irrespective of animal longevity. The low DBI and PI
observed in long-lived species are due to changes in the type of
unsaturated fatty acid that participates in membrane composition. So,
there is a systematic redistribution between the types of PUFAs present
from the highly unsaturated 22:6n-3 and sometimes 20:4n-6 in short-
lived animals to the less unsaturated 18:2n-6, and, in some cases
18:3n-3 in the long-lived ones, at mitochondrial and tissue level.
Furthermore, the DBI of the respective diets did not correlate with
maximum longevity. This indicates again that the contribution of the
variations in the degree of unsaturation of dietary fats to the inter-
species differences is, if any, very modest.
What are the mechanisms responsible for these longevity-related
differences in fatty acid proﬁle? They can be related, in principle, to the
fatty acid desaturationpathway, and the deacylation–reacylation cycle.
The available estimates of delta-5 and delta-6 desaturase activities
indicate that they are several folds lower in long-lived species than in
short-lived ones [18,35]. This can explain why 22:6n-3 and 20:4n-6
decreases, and 18:2n-6 and 18:3n-3 increases, from short- to long-
lived animals, since desaturases are the rate-limiting enzymes of the n-
3 and n-6 pathways synthesizing the highly unsaturated PUFAs 20:4n-
6 and 22:6n-3 from their dietary precursors, 18:2n-6 and 18:3n-3,
respectively. Thus, desaturationpathwayswouldmake available in situ
the n-6 and n-3 fatty acids to phospholipid acyltransferases in order to
remodel the phospholipid acyl groups. The fact that acyltransferase/n-
6 desaturase activity ratio is about 10:1 in tissues [162] reinforces the
idea that regulation of desaturases can be the main limiting factor
responsible for the observed membrane unsaturation-longevity
relationship. However, a role for a phospholipid-speciﬁc deacyla-
tion–reacylation system cannot be discarded since it has been
observed that the longevity-related redistribution particularly affects
the phosphatidylcholine and phosphatidyletanolamine fractions in
liver mitochondria, and does not modify cardiolipin [11].
Animals with a high maximum longevity have a low degree of
membrane fatty acid desaturation based in the redistribution between
types of PUFAs without any alteration in the total (%) PUFA content,
average chain length, and phospholipid distribution. This may be
viewed as an elegant evolutionary strategy, because it decreases the
sensitivity to lipid peroxidation and lipoxidation-derived damage to
cellular macromolecules without strongly altering ﬂuidity/microvisc-
osity, a fundamental property of cellular membranes for the proper
function of receptors, ion pumps, and transport of metabolites. This
would occur because membrane ﬂuidity increases acutely with the
introduction of the ﬁrst and less with the second double bond (due to
their introduction of “kinks” in the fatty acid molecule), whereas
additional (the third and following) double bonds cause few further
variations in ﬂuidity [163]. This is so because the kink has a larger
impact on ﬂuidity when the double bond is situated near the centre ofthe fatty acid chain (ﬁrst double bond) than when it is situated
progressively nearer to its extremes (next double bond additions). In
the case of the sensitivity to lipid peroxidation, however, double bonds
increase it irrespective of their location at the centre or laterally on the
fatty acids. Thus, by substituting fatty acids with four or six double
bonds by those having only two (or sometimes three) double bonds,
the sensitivity to lipid peroxidation is strongly decreased in long-lived
animals, whereas the ﬂuidity of the membrane would be essentially
maintained. This hypothesis, reminiscent of membrane acclimation to
different environments at PUFA level in poikilotherms and bacteria,
has been denominated homeoviscous longevity adaptation [18].
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